Long-term Treatment of Steroid-dependent Myasthenia Gravis Patients with Low-dose Tacrolimus
Author:
Affiliation:
1. Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine
2. Department of Neurology, Kanazawa Medical University
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
http://www.jstage.jst.go.jp/article/internalmedicine/47/8/47_8_731/_pdf
Reference18 articles.
1. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis
2. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis
3. Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study
4. Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus)
5. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Treatment of Myasthenia Gravis;Journal of Clinical Medicine;2022-03-14
2. Utilization of MG‐ADL in myasthenia gravis clinical research and care;Muscle & Nerve;2022-01-06
3. Principles and Guidelines of Immunotherapy in Neuromuscular Disorders;Neuromuscular Disorders;2022
4. Update in immunosuppressive therapy of myasthenia gravis;Autoimmunity Reviews;2021-01
5. Immunosuppression in Multiple Sclerosis and Other Neurologic Disorders;Pharmacology of Immunosuppression;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3